Torrent Pharmaceuticals has raised funds worth Rs 200 crore through issue of Non-Convertible Debentures (NCDs) on Private Placement basis on May 14, 2020. The tenure of the instrument is 1072 days and will mature on April 21, 2023.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.